Curaleaf Enters Europe Cannabis Market in $285 Million Deal (2)

Curaleaf Holdings Inc. agreed to buy Emmac Life Sciences Ltd. for about $285 million, giving the company entry into Europe’s rapidly growing cannabis market.

“By doing this transaction, Curaleaf is indisputably the largest operator on a revenue and a footprint basis around the globe,” Executive Chairman Boris Jordan said in an interview Tuesday. With a market capitalization about $11 billion, Curaleaf is already the largest U.S.-based multistate operator.

The acquisition of Europe’s largest cannabis company by footprint is poised to turn Curaleaf into a dominant player internationally, giving it a new presence in eight countries. The tie-up will also allow ...